If you or a loved one has been diagnosed with a serious health concern, such as stomach, small intestine, colorectal, esophageal, bladder, prostate, blood, or liver cancers, as well as leukemia, Non-Hodgkin’s Lymphoma, or multiple myeloma after using prescription or over the counter Zantac or a generic version, ranitidine we urge you to contact our pharmaceutical liability attorneys by calling 1.800.556.5522 or by filling out the form below. You may be entitled to pursue legal action.
What is Zantac?
Zantac is an antacid and antihistamine primarily used to treat and prevent heartburn, but can also be used to treat stomach ulcers, gastroesophageal reflux disease (GERD) and other gastrointestinal disorders. The drug is known as ranitidine in its generic form.
Drug safety officials in the U.S. and Europe have launched an investigation into whether Sanofi heartburn medication, Zantac, and other generic versions made by numerous manufacturers contain levels of the probable carcinogen N-nitrosodimethylamine (NDMA) that could pose a danger to patients
What is NDMA?
NDMA is common industrial byproduct and is a contaminant found in small quantities in meat, vegetables, dairy and water. It is classified as a probable human carcinogen, meaning that it is a substance that could cause cancer when consumed in certain quantities.
What are the Injuries Associated with Zantac and its Generic Counterparts?
Known adverse effects of exposure to NDMA include:
- Abdominal pain
- Reduced organ function
It is important that consumers who have experienced any of these symptoms after taking Zantac contact a medical professional and report the adverse effect using the FDA’s MedWatch reporting system.
What Companies are Involved in Litigation?
The discovery of traces of NDMA found in generic Zantac led major drug manufacturers to recall their products. Specific lots of the popular over-the-counter medication have been voluntarily pulled from shelves by numerous manufacturing and distribution companies all over the world, including Sandoz Inc., GlaxoSmithKline—the original manufacturer of branded Zantac—and Dr. Reddy’s. The recent contamination concerns led Sandoz Inc. to halt the distribution of its product indefinitely until further decisions are made regarding the safety of the product. Sandoz Inc. will voluntarily recall all quantities and lots of Ranitidine Hydrochloride (Zantac) that have expiration dates between April 30, 2020 and March 31, 2021, as those lots have been confirmed to be contaminated with NDMA.
What are the Symptoms of NDMA Over-Exposure?
Symptoms of NDMA over-exposure include:
- abdominal cramps
- enlarged liver
- reduced function of the liver, kidneys and lungs
- and dizziness
Contact the Pharmaceutical Liability Attorneys at The Law Offices of Peter Angelos Today.
The recent discovery of traces of NDMA in popular drug Zantac and other generic versions of the drug is alarming and demonstrates the necessity of mass-manufactured pharmaceutical drug companies to ensure proper steps are being taken to uphold public health. The pharmaceutical liability attorneys at The Law Offices of Peter Angelos urge you to fill out the form below if you or a loved one has taken Zantac or ranitidine that contains NDMAs.